Alepam 200mg/28.5mg Tablet DT belongs to a group of antibiotics known as penicillin antibiotics. It is generally prescribed to prevent middle ear and sinus infections, throat or lung respiratory tract infections, urinary tract infections, skin infections, soft tissue infections, dental infections, and joint and bone infections.

Alepam 200mg/28.5mg Tablet DT consists of two medicines: Amoxycillin and Clavulanic acid. Amoxycillin acts by destroying the outer protein layer, thereby killing the bacteria (bactericidal action). Clavulanic acid inhibits the enzyme beta-lactamase, which prevents bacteria from destroying the efficacy of amoxycillin. As a result, the action of Clavulanic acid allows Amoxycillin to work better and kill the bacteria. Alepam 200mg/28.5mg Tablet DT does not work against infections caused by viruses, including colds and flu.

The dose of Alepam 200mg/28.5mg Tablet DT can vary depending on your condition and the severity of the infection. Also, it is recommended to complete the course of medicine even if you feel better as it is an antibiotic, and leaving it in between may lead to even severe infection that will, in fact, stop responding to the antibiotic as well (antibiotic resistance). The common side effects of Alepam 200mg/28.5mg Tablet DT include vomiting, nausea, and diarrhoea. Everyone may not experience the above side effects. In case of any discomfort, speak with a doctor.

Before starting Alepam 200mg/28.5mg Tablet DT, please inform your doctor if you have any allergy (against any antibiotic) or kidney or liver problems. Do not take Alepam 200mg/28.5mg Tablet DT on your own as self-medication since it may lead to antibiotic resistance in which antibiotics fail to act against specific bacterial infections. Alepam 200mg/28.5mg Tablet DT is safe for children if prescribed by a doctor; the dose and duration may vary depending on the child’s weight and the severity of the infection. Inform your doctor about all the medicines you are taking and about your health condition to rule out any unpleasant side effects.

Alepam 200mg/28.5mg Tablet DT is a broad-spectrum antibiotic that covers a very wide range of bacterial infections. Alepam 200mg/28.5mg Tablet DT has Clavulanic acid, which protects amoxycillin from getting destroyed by the bacterial enzyme, thus increasing its efficacy. Besides this, it helps overcome antibiotic resistance in bacteria that is caused by the enzyme beta-lactamase. This makes the drug effective in multiple infections like ear infections (acute otitis media), bronchitis, pneumonia, urinary tract infections, skin infections, etc.

After taking Alepam 200mg/28.5mg Tablet DT, if you have an allergy-like symptom, including rash, swelling of the face/lips/throat, difficulty breathing, or tight chest tightness, immediately contact your doctor. Do not take Alepam 200mg/28.5mg Tablet DT if you have an allergy to Alepam 200mg/28.5mg Tablet DT, penicillin or cephalosporin class of antibiotics. People with liver diseases or jaundice (yellowing of skin/eye) should not take Alepam 200mg/28.5mg Tablet DT, as it can severely affect the liver. Consult your doctor before taking Alepam 200mg/28.5mg Tablet DT if you are pregnant or breastfeeding. Inform your doctor about all the medicines you are taking and about your health condition to rule out any unpleasant side effects.

• Even if you feel better after taking Alepam 200mg/28.5mg Tablet DT, do not stop taking it until your doctor says so. This might cause the symptoms to reappear and make the infection difficult to treat due to antibiotic resistance.
• Make sure you drink plenty of fluids when you are sick. This will, in general, help you clear out the infection faster, protect you from dehydration, and help you overcome some unpleasant side effects of taking Alepam 200mg/28.5mg Tablet DT.
• Some people may be allergic to Alepam 200mg/28.5mg Tablet DT or other penicillin or cephalosporin group of antibiotics. So a prior sensitivity test may be necessary. Inform your doctor if you are allergic to any medicine, particularly antibiotics belonging to these groups.